Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.97 | 12.78 |
| PEG Ratio (TTM) | 0.00 | -0.12 |
| P/S Ratio (TTM) | 0.00 | 3.14 |
| P/B Ratio (TTM) | 0.01 | 2.30 |
| P/FCF Ratio (TTM) | 0.14 | 9.34 |
| Price to 5YR AVG Earnings Ratio | 0.08 | 13.66 |
| Price to 5YR AVG FCF Ratio | 0.03 | 4.39 |
Profitability (3%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.56% | -4.92% |
| ROE (TTM) | -0.70% | 17.75% |
| Net Profit Margin (TTM) | -1.95% | -106.34% |
| ROIC 5YR AVG | 1.60% | 37.51% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 9,135.91% | 32.30% | 100.03% |
| Revenue | 11.34% | 521.59% | 430.85% |
| Net Income | -65.91% | 15.37% | 137.63% |
| Cash Flow | 5.67% | -327.59% | -181.72% |
Health (65%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 6.93 | 1.75 |
| Quick Ratio (TTM) | 6.62 | 1.22 |
| D/E Ratio (TTM) | 0.02 | 0.39 |
| Interest Coverage (TTM) | -2.54 | 12.60 |
| Piotroski F-Score | 4 | 5 |
| Altman Z-Score | 0.70 | 3.89 |
| LTL to 5YR AVG FCF | 0.01 | -0.70 |
| Shares Outstanding Growth 5YR AVG | 187.01% | -0.04% |